Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review

• मुख्य लेखकों: Tayná F. G. S. Bandeira (लेखक), Luciana C. Marti (लेखक), Edna T. Rother (लेखक), Lucas Reis Correia (लेखक), Clarisse M. Machado (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2024-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Cytomegalovirus (CMV) poses a significant threat to post-hematopoietic cell transplantation (HCT). Control strategies include letermovir prophylaxis or ganciclovir pre-emptive therapy (PET). Without prophylaxis, 65-90% of seropositive recipients develop a clinically significant CMV infection. Due to...